A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia
Top Cited Papers
- 18 January 2009
- journal article
- research article
- Published by Springer Nature in Nature Genetics
- Vol. 41 (2), 187-191
- https://doi.org/10.1038/ng.309
Abstract
Kumarasamy Thangaraj and colleagues describe the association of a 25-bp deletion in MYBPC3 with heritable cardiomyopathies in Indian populations. They find a high prevalence (4–8%) of the deletion in surveyed Indian populations and an absence of the deletion in surveyed populations outside of Southeast Asia. Heart failure is a leading cause of mortality in South Asians. However, its genetic etiology remains largely unknown1. Cardiomyopathies due to sarcomeric mutations are a major monogenic cause for heart failure (MIM600958). Here, we describe a deletion of 25 bp in the gene encoding cardiac myosin binding protein C (MYBPC3) that is associated with heritable cardiomyopathies and an increased risk of heart failure in Indian populations (initial study OR = 5.3 (95% CI = 2.3–13), P = 2 × 10−6; replication study OR = 8.59 (3.19–25.05), P = 3 × 10−8; combined OR = 6.99 (3.68–13.57), P = 4 × 10−11) and that disrupts cardiomyocyte structure in vitro. Its prevalence was found to be high (∼4%) in populations of Indian subcontinental ancestry. The finding of a common risk factor implicated in South Asian subjects with cardiomyopathy will help in identifying and counseling individuals predisposed to cardiac diseases in this region.This publication has 29 references indexed in Scilit:
- A second generation human haplotype map of over 3.1 million SNPsNature, 2007
- Risk Factors for Early Myocardial Infarction in South Asians Compared With Individuals in Other CountriesJAMA, 2007
- Cardiac myosin binding protein c phosphorylation is cardioprotectiveProceedings of the National Academy of Sciences, 2006
- Correlation of regional cardiovascular disease mortality in India with lifestyle and nutritional factorsInternational Journal of Cardiology, 2006
- Biomolecular interactions between human recombinant β-MyHC and cMyBP-Cs implicated in familial hypertrophic cardiomyopathyCardiovascular Research, 2003
- Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathyJournal of Molecular and Cellular Cardiology, 2003
- Phenotypic Deficits in Mice Expressing a Myosin Binding Protein C Lacking the Titin and Myosin Binding DomainsJournal of Molecular and Cellular Cardiology, 2001
- COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytesJournal of Molecular Biology, 1999
- Mutations in β-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-CJournal of Molecular Biology, 1999
- A Molecular Map of the Interactions between Titin and Myosin‐Binding Protein CEuropean Journal of Biochemistry, 1996